Press Releases

 

 
Press Releases
Date Title and Summary View
Nov 12, 2014 RANCHO CUCAMONGA, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2014. Net revenues of $59.7 million for the third quarter GAAP net loss of $5.4 million or $0.12 per diluted share for the third quarter ...
Nov 4, 2014 RANCHO CUCAMONGA, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its third quarter of 2014 ended September 30, 2014, after the market closes on Wednesday, November 12, 2014, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacifi...
Aug 12, 2014 RANCHO CUCAMONGA, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2014. Net revenues of $49.0 million for the second quarter GAAP net loss of $1.2 million or $0.03 per diluted share for the second quarter ...
Aug 5, 2014 RANCHO CUCAMONGA, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its second quarter of 2014 ended June 30, 2014, after the market closes on Tuesday, August 12, 2014, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. ...
Jun 30, 2014 RANCHO CUCAMONGA, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and inhalation products, today announced that the underwriter...
Jun 25, 2014 RANCHO CUCAMONGA, Calif., June 25, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Amphastar) (Nasdaq:AMPH), a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable and inhalation products, today announced the pricing of its i...
Page: FirstPrevious ...
5
= add release to Briefcase

 

Copyright © 2017 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States